The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/267232
LSL LIFESCIENCELEADER.COM MARCH 2014 8 EDITORIAL ADVISORY BOARD EAB ASK THE BOARD Have a response to our experts' answers? Send us an email to atb@lifescienceconnect.com . JOHN BALDONI Chair, Leadership Development Practice, N2growth RAFIK BISHARA, PH.D. Chair, Pharmaceutical Cold Chain Interest Group, PDA G. STEVEN BURRILL CEO & Founder, Burrill & Company WILLIAM F. CIAMBRONE EVP, Technical Operations, Shire RON COHEN, M.D. President and CEO Acorda Therapeutics, Inc. LAURIE COOKE CEO, Healthcare Businesswomen's Association (HBA) ALAN EISENBERG Executive VP, Emerging Companies and Bus. Dev., Biotechnology Industry Organization (BIO) BARRY EISENSTEIN, M.D. Senior VP, Scientif c Affairs Cubist Pharmaceuticals HEATHER ERICKSON President and CEO Life Sciences Foundation JEFFREY EVANS, PH.D. Life Science Entrepreneur TIM FREEMAN Director of Operations at Freeman Technology and Past Chair of the Process Analytical Technology Focus Group of AAPS RON GUIDO President, Lifecare Services, LLC LAURA HALES, PH.D. Founder, The Isis Group FRED HASSAN Chairman of the Board Bausch + Lomb JOHN HUBBARD, PH.D. Senior VP & Worldwide Head of Development Operations, Pf zer MAIK JORNITZ Founder, BioProcess Resources, LLC Immediate Past Chair, PDA MITCHELL KATZ, PH.D. Exec. Dir. of Medical Research Operations, Purdue Pharma, L.P. MARY ROSE KELLER Former VP Clinical Operations, Sangart NORMAN KLEIN Principal, Core Results TIMOTHY KRUPA President, TSK Clinical Development JOHN LAMATTINA, PH.D. Senior Partner, PureTech Ventures LYNN JOHNSON LANGER, PH.D. Director, Enterprise and Regulatory Affairs Program Center for Biotechnology Education, Johns Hopkins University CRAIG LIPSET Head of Clinical Innovation, Worldwide Research & Development, Pf zer GREG MACMICHAEL, PH.D. Global Head of Biologics Process R&D; Novartis JEROLD MARTIN Chairman Bio-Process Systems Alliance (BPSA) KENNETH I. MOCH President & CEO, Chimerix, Inc. BERNARD MUNOS Founder, InnoThink Center for Research in Biomedical Innovation MIKE MYATT Leadership Advisor, N2growth CAROL NACY, PH.D. CEO, Sequella, Inc. SESHA NEERVANNAN, PH.D. VP Pharmaceutical Development Allergan KEVIN O'DONNELL Senior Partner, Exelsius Cold Chain Mgt. Consultancy U.S., Chair, Int. Air Transport Assoc. Time & Temp. Task Force JOHN ORLOFF, M.D. Former Senior VP, CMO, Global Development, Novartis Pharma AG MARK PYKETT, PH.D. President and CEO Navidea Biopharmaceuticals JOHN REYNDERS, PH.D. Chief Information Off cer Moderna Therapeutics JAMES ROBINSON VP, Vaccine & Biologics Technical Operations, Merck MARK SNYDER, PH.D. Former Associate Director, Purif cation Process Development Bayer HealthCare LESLIE WILLIAMS Founder, President, and CEO ImmusanT What Is The Best Leadership Advice You Ever Received? Q Everyone has a life outside of work, and if that's not in balance, then work will suffer. I tell the people in my group two things: First, family comes f rst, and I expect you to work hard while you're at work, but not to do that more than 8 or so hours a day except on rare occasions. The second piece of advice is that you need to be a champion for your staff. They need to know that you stand behind them 100 percent of the time. This doesn't mean you believe they're always right. It means being willing to hear their side of the story every time and doing your utmost to validate and protect them. MARK SNYDER, PH.D. Snyder is manager of the process R&D; applications group in the Process Chromatography Division of Bio-Rad Laboratories. He spent f ve years at Scios (then California Biotechnology) on basic f broblast growth factor cloning and purif cation, followed by four years as manager of process development at XOMA. A TWO PIECES OF ADVICE STAND OUT TO ME. THE FIRST IS TO REMEMBER YOU'RE DEALING WITH PEOPLE, NOT MACHINES. They forget, they get misfocused, they need to be constantly reminded about what we are doing and why. Martin Gerstel, CEO of ALZA, told me in the mid-1970s that after running ALZA for years he realized that keeping the team "on focus" was the most important thing a CEO could do. Also, remember that determining what the strategy is and the tactics to achieve it are critical — and not easy. But once f gured out, staying on task is fundamental. A KEEP FOCUSED ON THE STRATEGY, AND KEEP REMINDING THE TEAM OF WHAT THE STRATEGY IS. G. STEVEN BURRILL Burrill founded Burrill & Company as a logical extension of his 40-year involvement in the growth and prosperity of the biotechnology industry. He has been an active adviser and catalyst in some of the industry's most notable companies and transactions. While this Spike Lee movie title seems too simple, it is a reminder that some- times we overly complicate decisions. I encourage emerging leaders to stop and ask themselves what is the right thing , separating out all of the "noise" of other interests. Much of the time, the right thing to do is actually very clear. CRAIG LIPSET Lipset is head of clinical innovation within worldwide R&D; at Pf zer. In this role, he works across units and stakeholders to def ne Pf zer's vision for the future of clinical trials and enables the initiatives and investments to create that future. A ALWAYS DO THE RIGHT THING . 0 3 1 4 _ E A B 0 1 . i n d d 1 0314_EAB01.indd 1 2 / 1 9 / 2 0 1 4 2 : 0 3 : 3 5 P M 2/19/2014 2:03:35 PM